News
The company has predicted that Imaavy — now approved for generalized myasthenia gravis — could eventually earn more than $5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback